Co-Authors
This is a "connection" page, showing publications co-authored by PREMA ROBINSON and EMMA RODRIGUEZ.
Connection Strength
2.553
-
Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871. Cancers (Basel). 2021 Oct 15; 13(20).
Score: 0.840
-
Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers (Basel). 2021 Jul 31; 13(15).
Score: 0.828
-
Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis. Cancers (Basel). 2023 May 30; 15(11).
Score: 0.235
-
Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn's Disease. J Clin Med. 2022 Nov 28; 11(23).
Score: 0.227
-
Substance P-Friend or Foe. J Clin Med. 2022 Jun 22; 11(13).
Score: 0.220
-
Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity. Cancers (Basel). 2021 Apr 06; 13(7).
Score: 0.203